We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Prevention of Early Asthma in Kids (PEAK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00272441
Recruitment Status : Completed
First Posted : January 6, 2006
Last Update Posted : July 12, 2016
Childhood Asthma Research and Education Network
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)

Brief Summary:
To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.

Condition or disease Intervention/treatment Phase
Asthma Lung Diseases Drug: inhaled corticosteroids Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
Study Start Date : January 2001
Actual Study Completion Date : September 2004

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Asthmatic children from birth to 18 years. Emphasis is placed on infants and young children through 5 years of age.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00272441

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Childhood Asthma Research and Education Network
Layout table for investigator information
OverallOfficial: Vernon Chinchilli Milton S. Hershey Medical Center
OverallOfficial: Robert Lemanske University of Wisconsin, Madison
OverallOfficial: Fernando Martinez University of Arizona
OverallOfficial: Robert Strunk Washington University School of Medicine
OverallOfficial: Stanley Szefler National Jewish Health
OverallOfficial: Robert Zeiger University of California, San Diego
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00272441    
Obsolete Identifiers: NCT00000622
Other Study ID Numbers: 350
First Posted: January 6, 2006    Key Record Dates
Last Update Posted: July 12, 2016
Last Verified: January 2008
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases